Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma.
Mol Ther Oncolytics. 2021 Mar 17;21:37-46. doi: 10.1016/j.omto.2021.03.008. eCollection 2021 Jun 25.
Mol Ther Oncolytics. 2021.
PMID: 33869741
Free PMC article.
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.
Fotaki G, Jin C, Kerzeli IK, Ramachandran M, Martikainen MM, Karlsson-Parra A, Yu D, Essand M.
Fotaki G, et al. Among authors: martikainen mm.
Oncoimmunology. 2017 Dec 26;7(3):e1397250. doi: 10.1080/2162402X.2017.1397250. eCollection 2018.
Oncoimmunology. 2017.
PMID: 29399398
Free PMC article.
Item in Clipboard
Cite
Cite